Horikoshi N, Tashiro F, Tanaka N, Ueno Y
Department of Toxicology and Microbial Chemistry, Faculty of Pharmaceutical Sciences, Science University of Tokyo, Japan.
Cancer Res. 1988 Sep 15;48(18):5188-92.
Employing Reuber rat hepatoma cells, H4-II-E, the effects of aflatoxin B1 (AFB1) and sterigmatocystin (STC), which exhibit a similar cytotoxicity but a marked difference in hepatocarcinogenicity, on the hormonal induction of tyrosine aminotransferase (TAT), on glucocorticoid receptors, and on their nuclear acceptor sites were investigated. AFB1 strongly inhibited hydrocortisone-inducible TAT activity. The IC50 value was 0.2 micrograms/ml. AFB1 also showed weak inhibitory effects on insulin- and dibutyryl cyclic AMP-inducible TAT activities. In contrast, the IC50 of STC on hydrocortisone-inducible TAT activity was 3.5 micrograms/ml, about 10 times higher than that of AFB1. Dibutyryl cyclic AMP- and insulin-inductions were not depressed by STC. AFB1 inhibited the formation of cytosolic glucocorticoid receptor-hormone complexes (GRCs) but STC did not. Moreover, AFB1, activated in vitro by the microsomal cytochrome P-450 system, interfered more markedly in the formation of cytosolic GRCs than STC did. Sucrose density gradient analysis of GRCs and Scatchard analysis revealed that AFB1 and STC mainly impaired glucocorticoid receptors and GRC-acceptor sites, respectively. The present data suggest a marked difference between AFB1 and STC with regard to the inhibition of hormonal induction of liver specific enzymes.
利用鲁伯大鼠肝癌细胞H4-II-E,研究了黄曲霉毒素B1(AFB1)和柄曲霉素(STC)对酪氨酸转氨酶(TAT)的激素诱导、糖皮质激素受体及其核受体位点的影响。AFB1和STC具有相似的细胞毒性,但在肝癌致癌性上有显著差异。AFB1强烈抑制氢化可的松诱导的TAT活性,IC50值为0.2微克/毫升。AFB1对胰岛素和二丁酰环磷酸腺苷诱导的TAT活性也有微弱的抑制作用。相比之下,STC对氢化可的松诱导的TAT活性的IC50为3.5微克/毫升,约为AFB1的10倍。STC不会抑制二丁酰环磷酸腺苷和胰岛素的诱导作用。AFB1抑制胞质糖皮质激素受体-激素复合物(GRC)的形成,但STC不会。此外,经微粒体细胞色素P-450系统体外激活的AFB1,对胞质GRC形成的干扰比STC更明显。对GRC进行蔗糖密度梯度分析和Scatchard分析表明,AFB1和STC主要分别损害糖皮质激素受体和GRC受体位点。目前的数据表明,AFB1和STC在抑制肝脏特异性酶的激素诱导方面存在显著差异。